ESSA Financial Statements From 2010 to 2024

Stocks USA . 
Stock . ESSA Pharma
EPIX Stock  USD 1.79  0.02  1.10%   
ESSA Pharma financial statements provide useful quarterly and yearly information to potential ESSA Pharma investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ESSA Pharma financial statements helps investors assess ESSA Pharma's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ESSA Pharma's valuation are summarized below:
Market Capitalization
79.5 M
Earnings Share
(0.62)
We have found one hundred twenty available fundamental signals for ESSA Pharma, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of ESSA Pharma prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself next year. Market Cap is likely to drop to about 61.5 K in 2024. Enterprise Value is likely to drop to about 60.7 K in 2024
Check ESSA Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ESSA Pharma's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 5.9 K or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 272.8 K, Dividend Yield of 0.0 or PTB Ratio of 52.01. ESSA financial statements analysis is a perfect complement when working with ESSA Pharma Valuation or Volatility modules.
  
Check out the analysis of ESSA Pharma Correlation against competitors.
For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.

ESSA Pharma Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets180.1 M171.5 M69.9 M
Slightly volatile
Other Current Liabilities1.5 M1.6 M7.2 M
Slightly volatile
Total Current Liabilities3 M4 M2.7 M
Slightly volatile
Accounts Payable1.4 M2.3 M1.3 M
Slightly volatile
Cash34.1 M38.8 M29.6 M
Slightly volatile
Non Current Assets Total383.8 K374 K329.7 K
Slightly volatile
Cash And Short Term Investments178.8 M170.3 M59.5 M
Slightly volatile
Other Current Assets1.2 M673.2 K987.8 K
Slightly volatile
Total Liabilities4.6 M4 M3.9 M
Pretty Stable
Total Current Assets179.7 M171.1 M69.7 M
Slightly volatile
Intangible Assets271.4 K230.8 K218.7 K
Pretty Stable
Common Stock335.9 M319.9 M121.1 M
Slightly volatile
Liabilities And Stockholders Equity180.1 M171.5 M70 M
Slightly volatile
Property Plant And Equipment Net140.8 K78.2 K93.1 K
Slightly volatile
Common Stock Shares Outstanding53.2 M50.7 M18.2 M
Slightly volatile
Short and Long Term Debt Total68.7 K72.3 K4.4 M
Slightly volatile
Net Invested Capital103.4 M167.5 M63.3 M
Slightly volatile
Net Working Capital101.6 M167.1 M61.5 M
Slightly volatile
Capital Stock198.2 M319.9 M125.4 M
Slightly volatile

ESSA Pharma Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative7.5 M12.4 M6.5 M
Slightly volatile
Research Development25.7 M24.5 M11.3 M
Slightly volatile
Depreciation And Amortization75.6 K136.3 K64.6 K
Slightly volatile
Reconciled Depreciation87.8 K136.3 K70.7 K
Slightly volatile
Selling And Marketing Expenses18.1 K20.3 K22.1 K
Slightly volatile

ESSA Pharma Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow37.2 M38.8 M29.9 M
Slightly volatile
Stock Based Compensation6 M5.8 M1.6 M
Slightly volatile
Begin Period Cash Flow37.1 M65.6 M29.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio272.8 K306.9 K334.1 K
Slightly volatile
Days Sales Outstanding21.4 K24 K26.2 K
Slightly volatile
Invested Capital1 K1.2 K1.3 K
Slightly volatile
Average Payables865.7 K1.3 M1 M
Pretty Stable
Stock Based Compensation To Revenue4.6 K5.2 K5.6 K
Slightly volatile
Capex To Depreciation0.160.171.4496
Slightly volatile
EV To Sales239.6 K269.6 K293.6 K
Slightly volatile
Payables Turnover0.06230.05260.0611
Slightly volatile
Sales General And Administrative To Revenue20.8 K23.4 K25.5 K
Slightly volatile
Research And Ddevelopement To Revenue48.1 K54.2 K59 K
Slightly volatile
Capex To Revenue36.841.445.084
Slightly volatile
Cash Per Share1.071.12533.0003
Pretty Stable
Days Payables Outstanding8.1 K7.2 K11.1 K
Slightly volatile
Net Current Asset Value685770839
Slightly volatile
Income Quality1.280.94091.1146
Very volatile
Tangible Asset Value685770839
Slightly volatile
Intangibles To Total Assets0.380.360.252
Very volatile
Current Ratio7.067.435118.7169
Slightly volatile
Receivables Turnover0.0110.01230.0134
Slightly volatile
Graham Number12.8510.310411.2127
Very volatile
Capex Per Share0.00810.00850.0625
Slightly volatile
Average Receivables270.5 K284.8 K918.9 K
Slightly volatile
Revenue Per Share1.0E-41.0E-42.0E-4
Slightly volatile
Interest Debt Per Share2.0E-42.0E-40.6242
Very volatile
Debt To Assets0.0740.07790.7215
Slightly volatile
Days Of Payables Outstanding8.1 K7.2 K11.1 K
Slightly volatile
Ebt Per Ebit0.990.99930.9158
Very volatile
Long Term Debt To Capitalization0.30.321.8209
Slightly volatile
Total Debt To Capitalization0.07660.08061.0689
Slightly volatile
Quick Ratio14.487.435116.0333
Slightly volatile
Net Income Per E B T1.11.151.0224
Slightly volatile
Cash Ratio9.566.191810.6904
Slightly volatile
Days Of Sales Outstanding21.4 K24 K26.2 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.151.022
Slightly volatile
Fixed Asset Turnover0.00140.00150.0017
Slightly volatile
Debt Ratio0.0740.07790.7215
Slightly volatile
Price Sales Ratio272.8 K306.9 K334.1 K
Slightly volatile
Asset Turnover0.00.00.0
Slightly volatile
Operating Cycle21.3 K24 K26.1 K
Slightly volatile
Cash Conversion Cycle5.7 K6.4 K7 K
Slightly volatile

ESSA Pharma Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap61.5 K64.7 K48.5 M
Pretty Stable
Working Capital685770839
Slightly volatile

ESSA Fundamental Market Drivers

Cash And Short Term Investments148.1 M

ESSA Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
10th of December 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About ESSA Pharma Financial Statements

ESSA Pharma investors use historical fundamental indicators, such as ESSA Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ESSA Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue(304.20)(319.41)
Cost Of Revenue136.3 K143.1 K
Stock Based Compensation To Revenue5.2 K4.6 K
Sales General And Administrative To Revenue23.4 K20.8 K
Research And Ddevelopement To Revenue54.2 K48.1 K
Capex To Revenue 41.40  36.80 
Ebit Per Revenue-81.5 K-85.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Additional Tools for ESSA Stock Analysis

When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY